Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Translational Oncology|October 16, 2025
Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasmsBlanca De Moner, Julia Martinez-Sanchez, Silvia Escribano-Serrat, et al.
Bone Marrow Transplantation|January 31, 2023
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantationMiriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, et al.
Cytometry. Part B, Clinical Cytometry|May 13, 2026
Diagnostic performance of flow cytometric osmotic fragility testing in hereditary spherocytosisSilvia Escribano Serrat, Patricia Molina, Pilar Gómez, et al.
Frontiers in Medicine|November 30, 2023
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complicationsMarta Palomo, Ana Belén Moreno-Castaño, María Queralt Salas, et al.
Blood Advances|April 28, 2026
Endothelial Activation and Damage associated with Steroid-Refractory aGVHD is counteracted by RuxolitinibBlanca De Moner, Julia Martinez-Sanchez, Silvia Escribano-Serrat, et al.
Frontiers in Endocrinology|November 28, 2022
Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patientsInés Amich, Eduardo Anguita, Silvia Escribano-Serrat, et al.
Heart & Lung : the Journal of Critical Care|June 18, 2026
Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenatorsSilvia Escribano-Serrat, Ana Belén Moreno-Castaño, Marc Pino, et al.
Journal of Clinical Medicine|February 10, 2024
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular ResponseSílvia Marcé, Aleix Méndez, Blanca Xicoy, et al.
Transplantation and Cellular Therapy|November 24, 2023
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic TransplantationAlexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, et al.
Frontiers in Immunology|December 3, 2025
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpuraSilvia Escribano-Serrat, María Queralt Salas, Cristina Pascual-Izquierdo, et al.
Pageof 2